{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T01:14:35Z","timestamp":1783300475301,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Science and ICT (MSIT) of the government of Korea","award":["RS-2023-00208037"],"award-info":[{"award-number":["RS-2023-00208037"]}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"crossref","award":["2021IL0004"],"award-info":[{"award-number":["2021IL0004"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48024-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:06:15Z","timestamp":1777975575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The natural killer\u2013cellular humoral activation test as a functional biomarker of antibody-mediated rejection after kidney transplantation"],"prefix":"10.1038","volume":"16","author":[{"given":"Jin-Myung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hyeon","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunwook","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"48024_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/nejm199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe, R. A. et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl. J. Med. 341, 1725\u20131730. https:\/\/doi.org\/10.1056\/nejm199912023412303 (1999).","journal-title":"N Engl. J. Med."},{"key":"48024_CR2","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","volume":"11","author":"M Tonelli","year":"2011","unstructured":"Tonelli, M. et al. Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes. Am. J. Transplant. 11, 2093\u20132109. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03686.x (2011). https:\/\/doi.org\/.","journal-title":"Am. J. Transplant."},{"key":"48024_CR3","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1681\/asn.2018111101","volume":"30","author":"PA Clayton","year":"2019","unstructured":"Clayton, P. A., McDonald, S. P., Russ, G. R. & Chadban, S. J. Long-Term Outcomes after Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis. J. Am. Soc. Nephrol. 30, 1697\u20131707. https:\/\/doi.org\/10.1681\/asn.2018111101 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"48024_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.krcp.2015.06.003","volume":"34","author":"EH Koo","year":"2015","unstructured":"Koo, E. H. et al. The impact of early and late acute rejection on graft survival in renal transplantation. Kidney Res. Clin. Pract. 34, 160\u2013164. https:\/\/doi.org\/10.1016\/j.krcp.2015.06.003 (2015).","journal-title":"Kidney Res. Clin. Pract."},{"key":"48024_CR5","doi-asserted-by":"publisher","first-page":"e24439","DOI":"10.5812\/numonthly.24439","volume":"7","author":"M Jalalzadeh","year":"2015","unstructured":"Jalalzadeh, M., Mousavinasab, N., Peyrovi, S. & Ghadiani, M. H. The Impact of Acute Rejection in Kidney Transplantation on Long-Term Allograft and Patient Outcome. Nephro-Urol Mon. 7, e24439. https:\/\/doi.org\/10.5812\/numonthly.24439 (2015).","journal-title":"Nephro-Urol Mon"},{"key":"48024_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5500\/wjt.v4.i1.1","volume":"4","author":"M Salvadori","year":"2014","unstructured":"Salvadori, M. & Bertoni, E. Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J. Transpl. 4, 1\u201317. https:\/\/doi.org\/10.5500\/wjt.v4.i1.1 (2014).","journal-title":"World J. Transpl."},{"key":"48024_CR7","first-page":"46","volume":"17","author":"JC Garces","year":"2017","unstructured":"Garces, J. C. et al. Antibody-Mediated Rejection: A Review. Ochsner J. 17, 46\u201355 (2017).","journal-title":"Ochsner J."},{"key":"48024_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2215\/cjn.00700117","volume":"13","author":"R Zhang","year":"2018","unstructured":"Zhang, R. Donor-Specific Antibodies in Kidney Transplant Recipients. Clin. J. Am. Soc. Nephrol. 13, 182\u2013192. https:\/\/doi.org\/10.2215\/cjn.00700117 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"48024_CR9","doi-asserted-by":"publisher","first-page":"703457","DOI":"10.3389\/fimmu.2021.703457","volume":"12","author":"M Crespo","year":"2021","unstructured":"Crespo, M. et al. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection. Front. Immunol. 12, 703457. https:\/\/doi.org\/10.3389\/fimmu.2021.703457 (2021).","journal-title":"Front. Immunol."},{"key":"48024_CR10","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1097\/tp.0000000000003551","volume":"105","author":"T Kardol-Hoefnagel","year":"2021","unstructured":"Kardol-Hoefnagel, T. & Otten, H. G. A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies. Transplantation 105, 1459\u20131470. https:\/\/doi.org\/10.1097\/tp.0000000000003551 (2021).","journal-title":"Transplantation"},{"key":"48024_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrneph.2016.88","volume":"12","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. & Reed, E. F. The importance of non-HLA antibodies in transplantation. Nat. Rev. Nephrol. 12, 484\u2013495. https:\/\/doi.org\/10.1038\/nrneph.2016.88 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"48024_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1600-6143.2009.02985.x","volume":"10","author":"JM Gloor","year":"2010","unstructured":"Gloor, J. M. et al. Baseline Donor-Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation. Am. J. Transplant. 10, 582\u2013589. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02985.x (2010). https:\/\/doi.org\/.","journal-title":"Am. J. Transplant."},{"key":"48024_CR13","doi-asserted-by":"publisher","unstructured":"Gniewkiewicz, M., Czerwinska, K., Zielniok, K. & Durlik, M. Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes. J. Clin. Med. 12 https:\/\/doi.org\/10.3390\/jcm12103361 (2023).","DOI":"10.3390\/jcm12103361"},{"key":"48024_CR14","doi-asserted-by":"publisher","first-page":"11321","DOI":"10.3389\/ti.2023.11321","volume":"36","author":"DAJ van den Broek","year":"2023","unstructured":"van den Broek, D. A. J. et al. The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice. Transpl. Int. 36, 11321. https:\/\/doi.org\/10.3389\/ti.2023.11321 (2023).","journal-title":"Transpl. Int."},{"key":"48024_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3265\/Nefrologia.pre2013.Nov.12232","volume":"34","author":"C Tapia-Canelas","year":"2014","unstructured":"Tapia-Canelas, C. et al. [Complications associated with renal graft biopsy in transplant patients]. Nefrologia 34, 115\u2013119. https:\/\/doi.org\/10.3265\/Nefrologia.pre2013.Nov.12232 (2014).","journal-title":"Nefrologia"},{"key":"48024_CR16","doi-asserted-by":"publisher","unstructured":"Krishnamoorthy, S. & Kyeso, Y. Challenges of Diagnosing Antibody-Mediated Rejection: The Role of Invasive and Non-Invasive Biomarkers. Med. (Kaunas). 57. https:\/\/doi.org\/10.3390\/medicina57050439 (2021).","DOI":"10.3390\/medicina57050439"},{"key":"48024_CR17","doi-asserted-by":"publisher","unstructured":"Pontrelli, P. et al. The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation. Front. Immunol. 11 https:\/\/doi.org\/10.3389\/fimmu.2020.01454 (2020).","DOI":"10.3389\/fimmu.2020.01454"},{"key":"48024_CR18","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","volume":"10","author":"LG Hidalgo","year":"2010","unstructured":"Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transpl. 10, 1812\u20131822. https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03201.x (2010).","journal-title":"Am. J. Transpl."},{"key":"48024_CR19","doi-asserted-by":"publisher","unstructured":"Ruan, D. F. et al. High-dimensional analysis of NK cells in kidney transplantation uncovers subsets associated with antibody-independent graft dysfunction. JCI Insight. 9 https:\/\/doi.org\/10.1172\/jci.insight.185687 (2024).","DOI":"10.1172\/jci.insight.185687"},{"key":"48024_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/iji.12532","volume":"48","author":"MA O\u2019Neill","year":"2021","unstructured":"O\u2019Neill, M. A. & Hidalgo, L. G. NK cells in antibody-mediated rejection - Key effector cells in microvascular graft damage. Int. J. Immunogenet. 48, 110\u2013119. https:\/\/doi.org\/10.1111\/iji.12532 (2021).","journal-title":"Int. J. Immunogenet."},{"key":"48024_CR21","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1038\/s41598-019-52864-5","volume":"9","author":"HR Jung","year":"2019","unstructured":"Jung, H. R. et al. CD56(+)CD57(+) infiltrates as the most predominant subset of intragraft natural killer cells in renal transplant biopsies with antibody-mediated rejection. Sci. Rep. 9, 16606. https:\/\/doi.org\/10.1038\/s41598-019-52864-5 (2019).","journal-title":"Sci. Rep."},{"key":"48024_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2016.00288","volume":"7","author":"T Legris","year":"2016","unstructured":"Legris, T. et al. Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies. Front. Immunol. 7, 288. https:\/\/doi.org\/10.3389\/fimmu.2016.00288 (2016).","journal-title":"Front. Immunol."},{"key":"48024_CR23","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/ajt.15898","volume":"20","author":"A Loupy","year":"2020","unstructured":"Loupy, A. et al. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am. J. Transpl. 20, 2318\u20132331. https:\/\/doi.org\/10.1111\/ajt.15898 (2020).","journal-title":"Am. J. Transpl."},{"key":"48024_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.4049\/jimmunol.2400328","volume":"213","author":"P Pymm","year":"2024","unstructured":"Pymm, P. et al. The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6\/32. J. Immunol. 213, 876\u2013885. https:\/\/doi.org\/10.4049\/jimmunol.2400328 (2024).","journal-title":"J. Immunol."},{"key":"48024_CR25","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3389\/fimmu.2019.01354","volume":"10","author":"E Jun","year":"2019","unstructured":"Jun, E. et al. Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-\u03b21 Deregulation and Disease Progression in Pancreatic Cancer. Front. Immunol. 10, 1354. https:\/\/doi.org\/10.3389\/fimmu.2019.01354 (2019).","journal-title":"Front. Immunol."},{"key":"48024_CR26","doi-asserted-by":"publisher","first-page":"e2400920","DOI":"10.1002\/advs.202400920","volume":"11","author":"WS Choi","year":"2024","unstructured":"Choi, W. S. et al. HPK1 Dysregulation-Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression. Adv. Sci. (Weinh). 11, e2400920. https:\/\/doi.org\/10.1002\/advs.202400920 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"48024_CR27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1200\/JCO.2005.06.059","volume":"23","author":"SP Treon","year":"2005","unstructured":"Treon, S. P. et al. Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenstrom\u2019s macroglobulinemia. J. Clin. Oncol. 23, 474\u2013481. https:\/\/doi.org\/10.1200\/JCO.2005.06.059 (2005).","journal-title":"J. Clin. Oncol."},{"key":"48024_CR28","doi-asserted-by":"publisher","first-page":"913215","DOI":"10.3389\/fimmu.2022.913215","volume":"13","author":"L Coenon","year":"2022","unstructured":"Coenon, L. & Villalba, M. From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement. Front. Immunol. 13, 913215. https:\/\/doi.org\/10.3389\/fimmu.2022.913215 (2022).","journal-title":"Front. Immunol."},{"key":"48024_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fimmu.2019.01208","volume":"10","author":"P Paul","year":"2019","unstructured":"Paul, P. et al. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients\u2019 Survival After Lung Transplant. Front. Immunol. 10, 1208. https:\/\/doi.org\/10.3389\/fimmu.2019.01208 (2019).","journal-title":"Front. Immunol."},{"key":"48024_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.kint.2018.08.041","volume":"95","author":"T Yagisawa","year":"2019","unstructured":"Yagisawa, T. et al. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection. Kidney Int. 95, 350\u2013362. https:\/\/doi.org\/10.1016\/j.kint.2018.08.041 (2019).","journal-title":"Kidney Int."},{"key":"48024_CR31","doi-asserted-by":"publisher","DOI":"10.3791\/60714","author":"S Chava","year":"2020","unstructured":"Chava, S., Bugide, S., Gupta, R. & Wajapeyee, N. Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells. J. Vis. Exp. https:\/\/doi.org\/10.3791\/60714 (2020).","journal-title":"J. Vis. Exp."},{"key":"48024_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-3083.2011.02667.x","volume":"75","author":"R Valiathan","year":"2012","unstructured":"Valiathan, R. et al. Evaluation of a flow cytometry-based assay for natural killer cell activity in clinical settings. Scand. J. Immunol. 75, 455\u2013462. https:\/\/doi.org\/10.1111\/j.1365-3083.2011.02667.x (2012).","journal-title":"Scand. J. Immunol."},{"key":"48024_CR33","doi-asserted-by":"publisher","unstructured":"Kim, J. M. et al. Assessment of NK Cell Activity Based on NK Cell-Specific Receptor Synergy in Peripheral Blood Mononuclear Cells and Whole Blood. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21218112 (2020).","DOI":"10.3390\/ijms21218112"},{"key":"48024_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2016.00384","volume":"7","author":"MR Goodier","year":"2016","unstructured":"Goodier, M. R. et al. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Front. Immunol. 7, 384. https:\/\/doi.org\/10.3389\/fimmu.2016.00384 (2016).","journal-title":"Front. Immunol."},{"key":"48024_CR35","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","volume":"121","author":"R Romee","year":"2013","unstructured":"Romee, R. et al. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 121, 3599\u20133608. https:\/\/doi.org\/10.1182\/blood-2012-04-425397 (2013).","journal-title":"Blood"},{"key":"48024_CR36","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1083\/jcb.201712085","volume":"217","author":"K Srpan","year":"2018","unstructured":"Srpan, K. et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J. Cell. Biol. 217, 3267\u20133283. https:\/\/doi.org\/10.1083\/jcb.201712085 (2018).","journal-title":"J. Cell. Biol."},{"key":"48024_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","volume":"55","author":"K Karre","year":"2002","unstructured":"Karre, K. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55, 221\u2013228. https:\/\/doi.org\/10.1046\/j.1365-3083.2002.01053.x (2002).","journal-title":"Scand. J. Immunol."},{"key":"48024_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1681\/ASN.2020040433","volume":"32","author":"A Koenig","year":"2021","unstructured":"Koenig, A. et al. Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection. J. Am. Soc. Nephrol. 32, 479\u2013494. https:\/\/doi.org\/10.1681\/ASN.2020040433 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"48024_CR39","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","volume":"10","author":"A Koenig","year":"2019","unstructured":"Koenig, A. et al. Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants. Nat. Commun. 10, 5350. https:\/\/doi.org\/10.1038\/s41467-019-13113-5 (2019).","journal-title":"Nat. Commun."},{"key":"48024_CR40","doi-asserted-by":"publisher","unstructured":"Sorohan, B. M. et al. Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights. Biomedicines 10 https:\/\/doi.org\/10.3390\/biomedicines10071506 (2022).","DOI":"10.3390\/biomedicines10071506"},{"key":"48024_CR41","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/ndt\/gfw368","volume":"32","author":"J Bamoulid","year":"2017","unstructured":"Bamoulid, J. et al. Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects. Nephrol. Dial Transpl. 32, 1601\u20131608. https:\/\/doi.org\/10.1093\/ndt\/gfw368 (2017).","journal-title":"Nephrol. Dial Transpl."},{"key":"48024_CR42","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.3389\/ti.2023.11899","volume":"36","author":"L Benning","year":"2023","unstructured":"Benning, L. et al. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial. Transpl. Int. 36, 11899. https:\/\/doi.org\/10.3389\/ti.2023.11899 (2023).","journal-title":"Transpl. Int."},{"key":"48024_CR43","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1681\/ASN.2020060850","volume":"32","author":"R El Fekih","year":"2021","unstructured":"El Fekih, R. et al. Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. J. Am. Soc. Nephrol. 32, 994\u20131004. https:\/\/doi.org\/10.1681\/ASN.2020060850 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"48024_CR44","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1097\/TXD.0000000000000821","volume":"4","author":"SC Jordan","year":"2018","unstructured":"Jordan, S. C. et al. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients. Transpl. Direct. 4, e379. https:\/\/doi.org\/10.1097\/TXD.0000000000000821 (2018).","journal-title":"Transpl. Direct"},{"key":"48024_CR45","doi-asserted-by":"publisher","first-page":"21973","DOI":"10.1038\/s41598-022-26580-6","volume":"12","author":"WW Woud","year":"2022","unstructured":"Woud, W. W., Hesselink, D. A., Hoogduijn, M. J., Baan, C. C. & Boer, K. Direct detection of circulating donor-derived extracellular vesicles in kidney transplant recipients. Sci. Rep. 12, 21973. https:\/\/doi.org\/10.1038\/s41598-022-26580-6 (2022).","journal-title":"Sci. Rep."},{"key":"48024_CR46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fimmu.2020.00342","volume":"11","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study. Front. Immunol. 11, 342. https:\/\/doi.org\/10.3389\/fimmu.2020.00342 (2020).","journal-title":"Front. Immunol."},{"key":"48024_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","volume":"95","author":"S Yazdani","year":"2019","unstructured":"Yazdani, S. et al. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation. Kidney Int. 95, 188\u2013198. https:\/\/doi.org\/10.1016\/j.kint.2018.08.027 (2019).","journal-title":"Kidney Int."},{"key":"48024_CR48","doi-asserted-by":"publisher","first-page":"e0132484","DOI":"10.1371\/journal.pone.0132484","volume":"10","author":"U Hoffmann","year":"2015","unstructured":"Hoffmann, U. et al. NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging. PLoS One. 10, e0132484. https:\/\/doi.org\/10.1371\/journal.pone.0132484 (2015).","journal-title":"PLoS One"},{"key":"48024_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fimmu.2013.00046","volume":"4","author":"C Neudoerfl","year":"2013","unstructured":"Neudoerfl, C. et al. The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs. Front. Immunol. 4, 46. https:\/\/doi.org\/10.3389\/fimmu.2013.00046 (2013).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48024-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48024-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48024-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:25:19Z","timestamp":1783297519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48024-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48024"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48024-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of Asan Medical Center (reference number: 2021\u2009\u2212\u20090284) and was performed in strict accordance with the Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. Written informed consent was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent prior to enrollment in the study. The consent process included permission for the collection and analysis of clinical data and biospecimens, as well as the use of de-identified data for research and publication purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"20666"}}